BlueWind RENOVA iStim™ System for the Treatment of OAB
Public ClinicalTrials.gov record NCT03596671. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective Study to Assess the Efficacy and Safety of the BlueWind RENOVA iStim™ System in the Treatment of Patients Diagnosed With Overactive Bladder (OASIS - OverActive Bladder StImulation System Study)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The OASIS study is prospective, interventional, multi-center study to evaluate the safety and efficacy of the BlueWind RENOVA iStim™ implantable tibial neuromodulation System for the treatment of patients diagnosed with overactive bladder.
Study identification
- NCT ID
- NCT03596671
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 282 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 11, 2019
- Primary completion
- Oct 27, 2022
- Completion
- Jan 23, 2025
- Last update posted
- Sep 15, 2025
2019 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Irvine | Orange | California | 92868 | — |
| Kaiser Permanente | San Diego | California | 92110 | — |
| Norwalk Urology | Norwalk | Connecticut | 06850 | — |
| Florida Urology Partners | Tampa | Florida | 33615 | — |
| Comprehensive Urologic Care | Lake Barrington | Illinois | 60010 | — |
| Regional Urology, LLC | Shreveport | Louisiana | 71106 | — |
| Chesapeake Urology - Hanover | Hanover | Maryland | 21076 | — |
| Chesapeake Urology - Owing Mills | Owings Mills | Maryland | 21117 | — |
| Minnesota Urology | Woodbury | Minnesota | 55125 | — |
| Adult Pediatric Urology & Urogynecology | Omaha | Nebraska | 68114 | — |
| Duke Urogynecology | Durham | North Carolina | 27707 | — |
| Southern Urogynocology | West Columbia | South Carolina | 29169 | — |
| Sanford Health | Sioux Falls | South Dakota | 57105 | — |
| University of Washington | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03596671, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2025 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03596671 live on ClinicalTrials.gov.